Long-term outcome
| 0–6 M | 6–12 M | |||||
| Octogenarian | Non-octogenarian | Total | Octogenarian | Non-octogenarian | Total | |
| Patients | 168 | 505 | 673 | 151 | 496 | 647 |
| MALE*—n (%) | 14/114 (12.3) | 64/386 (16.6) | 78/500 (15.6) | 18/91 (19.8) | 48/299 (16.1) | 66/390 (16.9) |
| Amputation, ipsilateral*—n (%) | 3/126 (2.4) | 8/406 (2.0) | 11/532 (2.1) | 1/95 (1.1) | 2/308 (0.6) | 3/403 (0.7) |
| Re-intervention*—n (%) | 13/163 (0.8) | 59/503 (11.7) | 72/666 (10.8) | 17/145 (11.7) | 49/494 (9.9) | 66/639 (10.3) |
| Vascular surgery*—n (%) | 0/133 (0.0) | 2/382 (0.5) | 2/495 (0.4) | 0/92 (0.0) | 1/280 (0.3) | 1/372 (0.2) |
| MCE*—n (%) | 3/112 (2.7) | 15/356 (4.2) | 18/468 (3.8) | 1/87 (1.1) | 17/263 (6.5) | 18/350 (5.1) |
| Reported death*—n (%) | 17/168 (10.1) | 9/505 (1.8) | 26/673 (3.9) | 5/151 (3.3) | 11/496 (2.2) | 16/647 (2.5) |
| Survival rate†—% | 0.9027 (0.856, 0.950) | 0.981 (0.968, 0.993) | 0.961 (0.946, 0.977) | 0.868 (0.815, 0.922) | 0.956 (0.937, 0.975) | 0.934 (0.915, 0.954) |
*Number of events relative to patients alive with completed information on the respective variable.
†Survival rate per Kaplan-Meier estimate at 6 and 12 months.
MALE, major adverse limb event: ipsilateral amputation, re-intervention, and/or peripheral vascular surgery; MCE, major cardiac event: ACS, stroke, PCI, and/or CABG.